TEMPUS AI
Über TEMPUS AI, INC
Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
Tempus AI Inc at Morgan Stanley Technology, Media & Telecom Conference
03.03.2026
17:15
Konferenz-Präsentationen
Q1 2026 Tempus AI Inc Earnings Release
01.05.2026
20:00
Veröffentlichungen von Geschäftszahlen
Q2 2026 Tempus AI Inc Earnings Release
31.07.2026
20:00
Veröffentlichungen von Geschäftszahlen